93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03082937 (ClinicalTrials.gov)	January 31, 2017	27/2/2017	An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects	An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabo ...	Orphan Cholestatic Liver Diseases;Progressive Familial Intrahepatic Cholestasis;Alagille Syndrome;Pr ...	Drug: 3 mg [14C]-A4250 capsule	Albireo	NULL	Completed	30 Years	65 Years	Male	6	Phase 1	United Kingdom
2	NCT02360852 (ClinicalTrials.gov)	January 2015	14/1/2015	IBAT Inhibitor A4250 for Cholestatic Pruritus	An Exploratory, Phase IIa Study to Demonstrate the Safety and Efficacy of A4250in Patients With Prim ...	Biliary Cirrhosis, Primary	Drug: A4250	Sahlgrenska University Hospital, Sweden	Albireo	Terminated	18 Years	80 Years	All	9	Phase 2	Sweden
3	EUCTR2014-004070-42-SE (EUCTR)	09/12/2014	15/10/2014	Study to Demonstrate the Efficacy and Safety of A4250in Patients withPrimary Biliary Cirrhosis and C ...	An Exploratory, Phase IIa Cross-Over Study to Demonstrate the Efficacyand Safety of A4250in Patients ...	Primary biliary cirrhosis complicated by cholestatic pruritus.;Therapeutic area: Diseases [C] - Dige ...	Product Code: A4250	Sahlgrenska Academy	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 2	Sweden
4	NCT02963077 (ClinicalTrials.gov)	July 2013	1/11/2016	A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384	A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokineti ...	Orphan Cholestatic Liver Diseases;Primary Biliary Cirrhosis;Progressive Familial Intrahepatic Choles ...	Drug: A4250;Drug: CRC (A3384);Drug: Questran;Drug: Placebo	Albireo	NULL	Completed	18 Years	60 Years	Both	94	Phase 1	NULL

First Previous1Next Last